CytomX Therapeutics (CTMX) Earnings Analysis
CytomX Therapeutics (CTMX) next reports earnings on 2026-08-06, consensus EPS -0.11 USD. Last quarter (2026-05-07) it beat with EPS -0.1 USD vs -0.14 USD est (+28.6%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -9.22.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CTMX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.11 USD |
| Revenue estimate | 0.01B |
CTMX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.1 USD | -0.14 USD | +28.6% | Beat |
| 2026-03-16 | -0.22 USD | -0.08 USD | -175% | Miss |
| 2025-05-12 | 0.27 USD | 0.1248 USD | +116.3% | Beat |
| 2025-03-06 | 0.22 USD | -0.23 USD | +195.7% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
CTMX valuation and analyst view
| Trailing P/E | -9.22 |
|---|---|
| Trailing EPS | -0.33362 USD |
| Price / book | 1.85 |
| Dividend yield | 0.00% |
| Market cap | 0.54B |
| Analyst consensus | Buy (17 buy / 4 hold / 0 sell) |
| Avg price target | 8.5 USD |
Related research pages
Frequently asked questions
When is CytomX Therapeutics (CTMX)'s next earnings date?
CytomX Therapeutics is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.11 USD and revenue estimate of 0.01B.
Did CTMX beat earnings last quarter?
In its 2026-05-07 report, CTMX posted EPS of -0.1 USD versus a -0.14 USD estimate — a beat of 28.6%.
What is CTMX's earnings track record?
Over the last 4 reported quarters with consensus data, CTMX beat estimates 3 times (75%).
What is CTMX's current P/E ratio and EPS?
CTMX trades at a trailing P/E of -9.22 on trailing EPS of -0.33361538418146025 USD.
What do analysts rate CTMX?
Analyst consensus is "Buy" across 21 ratings (0 strong buy, 17 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 8.5 USD.